Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease.

OBJECTIVE Cardiopulmonary bypass suppresses circulating thyroid hormone levels. Although acute triiodothyronine repletion has been evaluated in adult patients after cardiopulmonary bypass, triiodothyronine pharmacokinetics and effects have not previously been studied in infants undergoing operations for congenital heart disease. We hypothesized that triiodothyronine deficiency in the developing heart after bypass may adversely affect cardiac function reserve postoperatively. METHODS Infants less than 1 year old undergoing ventricular septal defect or tetralogy of Fallot repair were randomized into 2 groups. Group T (n = 7) received triiodothyronine (0.4 microg/kg) immediately before the start of cardiopulmonary bypass and again with myocardial reperfusion. Control (NT, n = 7) patients received saline solution placebo or no treatment. RESULTS These groups underwent similar ischemic and bypass times and received similar quantities of inotropic agents after the operation. The NT group demonstrated significant depression in circulating levels, compared with prebypass levels, for free triiodothyronine and total triiodothyronine at 1, 24, and 72 hours after bypass. Group T demonstrated similar low thyroxine values, but free and total triiodothyronine levels were maintained at prebypass levels for 24 hours and remained elevated over those of group NT (P <.05) at 72 hours. Heart rate was transiently elevated in group T compared with group NT (P <.05), and peak systolic pressure-rate product increased after 6 hours. CONCLUSION These data imply that (1) triiodothyronine in the prescribed dose prevents circulating triiodothyronine deficiencies and (2) triiodothyronine repletion promotes elevation in heart rate without concomitant decrease in systemic blood pressure. Elevation of peak systolic pressure-rate product implies that triiodothyronine repletion improves myocardial oxygen consumption and may enhance cardiac function reserve after cardiopulmonary bypass in infants.

[1]  R. Tucker,et al.  Thyroid Hormone Coordinates Respiratory Control Maturation and Adenine Nucleotide Translocator Expression in Heart In Vivo , 2000, Circulation.

[2]  R. Mainwaring,et al.  Pharmacokinetic evaluation of triiodothyronine supplementation in children after modified Fontan procedure. , 2000, Circulation.

[3]  S. Homma,et al.  A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. , 1999, The Journal of thoracic and cardiovascular surgery.

[4]  J. Hammon,et al.  Effects of Cardiopulmonary Bypass and Deep Hypothermic Circulatory Arrest on the Thyroid Axis During and After Repair of Congenital Heart Defects: Preservation by Deep Hypothermia? , 1998, Anesthesia and analgesia.

[5]  J S Child,et al.  Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. , 1998, The American journal of cardiology.

[6]  S. Bratton,et al.  Thyroid function in infants following cardiac surgery: comparative effects of iodinated and noniodinated topical antiseptics. , 1997, Critical care medicine.

[7]  R. Mainwaring,et al.  Effects of triiodothyronine supplementation following modified Fontan procedure , 1997, Cardiology in the Young.

[8]  M. Bettendorf,et al.  Transient Secondary Hypothyroidism in Children after Cardiac Surgery , 1997, Pediatric Research.

[9]  A. Wechsler,et al.  Triiodothyronine in cardiac surgery. , 1997, Thyroid : official journal of the American Thyroid Association.

[10]  J. Bavaria,et al.  Triiodothyronine optimizes sheep ventriculoarterial coupling for work efficiency. , 1996, The Annals of thoracic surgery.

[11]  M. Artman,et al.  Thyroid hormone regulates Na(+)-Ca2+ exchanger expression during postnatal maturation and in adult rabbit ventricular myocardium. , 1996, Cardiovascular research.

[12]  S. Thomas,et al.  Thyroid hormone treatment after coronary-artery bypass surgery. , 1995, The New England journal of medicine.

[13]  R. Mainwaring,et al.  Reduction in Triiodothyronine Levels Following Modified Fontan Procedure , 1994, Journal of cardiac surgery.

[14]  M. Yokoyama,et al.  Comparison of Hemodynamic Determinants for Myocardial Oxygen Consumption Under Different Contractile States in Human Ventricle , 1993, Circulation.

[15]  A. Rudolph,et al.  Effects of Thyroid Hormone on Myocardial Adrenergic β-Receptor Responsiveness and Function during Late Gestation , 1992, Pediatric Research.

[16]  B. Nadal-Ginard,et al.  Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated. , 1984, The Journal of biological chemistry.

[17]  J. Ratcliffe,et al.  Hypothalamo-pituitary-thyroid axis function during cardiopulmonary bypass. , 1978, The Journal of thoracic and cardiovascular surgery.

[18]  Kyuhyun Wang,et al.  Hemodynamic Predictors of Myocardial Oxygen Consumption During Static and Dynamic Exercise , 1974, Circulation.

[19]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.

[20]  P. Human,et al.  Inotropic effect of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: an experimental study in pigs. , 1988, The Annals of thoracic surgery.

[21]  E. Roti,et al.  Cardiopulmonary bypass: a low T4 and T3 syndrome with blunted thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH). , 1986, Hormone research.

[22]  M. Gibaldi.  Biopharmaceutics and clinical pharmacokinetics , 1977 .